Overview
Cutis laxa is a heterogeneous group of rare connective tissue disorders characterized by loose, redundant, and inelastic skin that hangs in folds, giving an aged appearance. The condition results from defects in elastic fiber formation, assembly, or maintenance. Cutis laxa can be inherited or acquired, and the inherited forms include autosomal dominant cutis laxa (ADCL), autosomal recessive cutis laxa (ARCL types 1, 2, and 3), and X-linked cutis laxa (also known as occipital horn syndrome). The disease affects multiple body systems beyond the skin, including the lungs (emphysema), cardiovascular system (aortic aneurysms, arterial tortuosity), gastrointestinal tract (diverticulae, hernias), and urogenital system (bladder diverticula). Skeletal abnormalities, developmental delay, and growth retardation may also occur, particularly in the autosomal recessive forms. The severity varies considerably depending on the genetic subtype. Autosomal dominant cutis laxa, often caused by mutations in the ELN (elastin) gene, tends to be milder with primarily cutaneous and pulmonary involvement. Autosomal recessive forms, associated with mutations in genes such as FBLN5, FBLN4 (EFEMP2), LTBP4, ATP6V0A2, PYCR1, ATP6V1E1, and others, are generally more severe and can be life-threatening in infancy due to cardiopulmonary complications. X-linked cutis laxa, caused by mutations in ATP7A, involves copper metabolism abnormalities and features skeletal anomalies including occipital exostoses. There is currently no cure for cutis laxa. Treatment is supportive and multidisciplinary, focusing on managing complications in affected organ systems. Surgical repair may be considered for hernias, and plastic surgery can address cosmetically significant skin laxity, although results may be temporary. Pulmonary and cardiovascular monitoring is essential. Genetic counseling is recommended for affected families to clarify the specific subtype and recurrence risk.
Variable
Can be inherited in different ways depending on the underlying gene
Variable
Can begin at different ages, from infancy through adulthood
FDA & Trial Timeline
10 eventsNordberg Medical AB — NA
Goldman, Butterwick, Fitzpatrick and Groff — PHASE2
Goldman, Butterwick, Fitzpatrick and Groff — PHASE4
303 Pharma s.r.l. — NA
Cytrellis Biosystems, Inc. — NA
Doris Hexsel — NA
Taumedika s.r.l. — NA
Osheru Inc. — NA
Goldman, Butterwick, Fitzpatrick and Groff — PHASE2
FA Corporation — NA
Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
Treatments
No FDA-approved treatments are currently listed for Cutis laxa.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Cutis laxa at this time.
New trials open frequently. Follow this disease to get notified.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Cutis laxa.
Community
No community posts yet. Be the first to share your experience with Cutis laxa.
Start the conversation →Latest news about Cutis laxa
Disease timeline:
New recruiting trial: An Evaluation of the Erchonia Laser As a Non-Invasive Treatment to Improve the Appearance of Skin Laxity
A new clinical trial is recruiting patients for Cutis laxa
New recruiting trial: Pure Impact Treatment to Strengthen and Tone Abdomen, Quadriceps and Glutes Muscles
A new clinical trial is recruiting patients for Cutis laxa
New recruiting trial: A Prospective Controlled Study to Evaluate the Safety and Effectiveness of Thermage® FLX Radiofrequency Treatment
A new clinical trial is recruiting patients for Cutis laxa
New recruiting trial: Treatment to Lift Facial Lax Skin and Improve Facial Wrinkles Using Precise and Lift Applicators
A new clinical trial is recruiting patients for Cutis laxa
New recruiting trial: Association of Leucocyte Telomere Length With DPAS Score in Skin Aging
A new clinical trial is recruiting patients for Cutis laxa
New recruiting trial: Effects of QUANTUM Probe for Skin Rejuvenation and Subdermal Retraction in Patients Undergoing High-Definition Liposculpture
A new clinical trial is recruiting patients for Cutis laxa
New recruiting trial: Ellacor® Micro-Coring Technology® in Fitzpatrick Skin Types I-VI, Including Patients Receiving Glucagon-Like Peptide-1 Receptor Agonists
A new clinical trial is recruiting patients for Cutis laxa
New recruiting trial: Safety and Effectiveness Evaluation of the High-intensity Focused Ultrasound Device for Lifting Lax Submental and Neck Tissue
A new clinical trial is recruiting patients for Cutis laxa
New recruiting trial: A Study to Characterize Human Skin Changes From Biostimulator Treatments Via Non-invasive Imaging
A new clinical trial is recruiting patients for Cutis laxa
New recruiting trial: Pre-marketing Trial to Assess Safety and Efficacy of 'Volumizing Filler Based on Hyaluronic Acid and Recombinant Collagen'
A new clinical trial is recruiting patients for Cutis laxa
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Cutis laxa
What is Cutis laxa?
Cutis laxa is a heterogeneous group of rare connective tissue disorders characterized by loose, redundant, and inelastic skin that hangs in folds, giving an aged appearance. The condition results from defects in elastic fiber formation, assembly, or maintenance. Cutis laxa can be inherited or acquired, and the inherited forms include autosomal dominant cutis laxa (ADCL), autosomal recessive cutis laxa (ARCL types 1, 2, and 3), and X-linked cutis laxa (also known as occipital horn syndrome). The disease affects multiple body systems beyond the skin, including the lungs (emphysema), cardiovascul
Which specialists treat Cutis laxa?
25 specialists and care centers treating Cutis laxa are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.